Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in! Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Emerging Approaches in Schizophrenia
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • View All
Back to top Open menu arrow
Download Free PDF

Save Save

Share Share

Cite Cite

Reprints
Sections
No sections available
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Access icon
Weight

Letter to the Editor April 1, 2002

Sleep Apnea Associated With Antipsychotic-Induced Obesity

Donna A. Wirshing ; Joseph M. Pierre ; William C. Wirshing

J Clin Psychiatry 2002;63(4):369-370

Article Abstract

Letter to the Editor

Sir: Weight gain and the development of obesity are known side effects of the novel antipsychotic drugs. We report 2 cases of obstructive sleep apnea that developed in the context of weight gain secondary to treatment with novel antipsychotic drugs.

 

Download Free PDF

This PDF is free for all visitors!

Save Save

Share Share

Cite Cite

Related News Articles

Circadian Rhythms Influence Caloric Intake Semaglutide Shows Promise in Curbing Alcohol Cravings Ozempic And Other Weight Loss Drugs Linked To Antidepressant Use

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

Administering Semaglutide With Long-Term Olanzapine Use Semaglutide-Induced Euphoria in a Patient With Bipolar Disorder Olanzapine/Samidorphan Effects on Weight Gain

Related PCC Articles

Phentermine–Induced Hypomania in Bipolar Depression Esketamine: Effects on Depression, Insomnia, and Weight GLP-1 Analogs in Patients on Antipsychotics

Vol 86 • 2025 • Number 2

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue

Related Articles

JCP
Letter to the Editor

Dr Grilo Replies

August 23, 2017

Carlos M. Grilo
PCC
Letter to the Editor

Something Positive From Something Negative

July 27, 2017

How would you help the patient with schizophrenia who believes that suicide is the only way to save his family? What about when he tries to starve himself? Read...
Robert G. Bota , Nabeel Wahid , Jessica J. Kim
PCC
Letter to the Editor

Ranitidine, Metformin, and Topiramate: Managing Weight Gain in a Clozapine-Treated Patient With Schizoaffective Disorder

June 15, 2014

O. Greg Deardorff , Ahsan Syed , Chelsea J. Ames , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap